eISSN: 1896-9151
ISSN: 1734-1922
Archives of Medical Science
Current issue Archive Special issues Abstracting and indexing Subscription
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
4/2007
vol. 3
 
Share:
Share:
abstract:

Review paper
Over a decade treating hepatocellular carcinoma percutaneously with radiofrequency thermal ablation. Worldwide experience

Loukas Thanos
,
Sofia Mylona
,
Nikolaos Ptohis
,
Eva Sotiropoulou
,
Anastasia Pomoni
,
Maria Pomoni

Arch Med Sci 2007; 3, 4: 293-304
Online publish date: 2008/01/09
View full text Get citation
 
Hepatocellular carcinoma (HCC) is a very common malignancy. Early diagnosis plays a significant role in the management of patients, affecting survival and prognosis. Surgical resection is the treatment of choice; yet only a small number of patients are surgical candidates at the time of diagnosis. Furthermore, recurrences are very common even after a successful resection. These reasons urged the need to introduce a minimally invasive technique that can be repeated, without the fear of increasing mortality, morbidity, hospitalization and treatment-related cost. In the present article we present our long-standing experience regarding radiofrequency thermal ablation (RFA) treatment of HCC. Indications, clinical results from other investigators and complications are discussed. Additionally there is a description of the technique and the equipment used.
keywords:

radiofrequency ablation, hepatocellular carcinoma, treatment, complications, indications, clinical results

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.